- December 23, 2021
- Posted by: Stratford Team
- Category: Business
Advisor Group chief market strategist Phil Blancato and Chris Verrone of Strategas react to increased market volatility on ‘Making Money.’
U.S. stocks rose for the second straight session as traders digested positive economic news and the Food and Drug Administration’s approval of Pfizer’s COVID-19 pill for use in adults and children ages 12 and older.
Ticker Security Last Change Change % I:DJI DOW JONES AVERAGES 35753.89 +261.19 +0.74%SP500 S&P 500 4696.56 +47.33 +1.02%I:COMP NASDAQ COMPOSITE INDEX 15521.89237 +180.81 +1.18%
The Dow Jones Industrial Average rose 261 points or 0.6% building on its 560 point advance on Tuesday while the S&P 500 and Nasdaq Composite rose 1% each.
Positive economic data included an uptick in the Consumer Confidence Index to the best level since July, a better than expected 3Q GDP report of 2.3%, albeit well below July’s 6.7% jump and home sales that rose 1.9%.
And the fight against COVID-19 also helped…
